Skip to main content

Tim Blauwkamp, co-Founder and Chief Scientific Officer of Karius, has been driving innovation in DNA sequencing, regenerative medicine, and microbiology for 20 years. At Karius, Dr. Blauwkamp’s work with microbial cell-free DNA enabled the launch of the world’s first liquid biopsy test for infectious disease. As Head of Molecular Biology for Moleculo he led the company’s long-read DNA sequencing assay development and commercial service, culminating with the company’s acquisition by Illumina.

Leave a Reply